Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 non-inferiority trial of beclometasone dipropionate inhalation aerosol in adults with asthma
CTR20253991Phase 3Active
- Sponsor
- Hefei Licheng Pharmaceutical
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in asthma, sponsored by Hefei Licheng Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20253991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253991.